21:36 IST
NSE
Acquisition
RPG Life Sciences Acquisition
RPG Life Sciences completed its acquisition of the entire stake in Actis Generics Private Limited, making it a subsidiary of the company.
RPG Life Sciences Ltd
- Share price
- ₹2,892.30
- Market cap
- ₹4,784 Cr
- Revenue (annual)
- ₹707.5 Cr
- Net profit (annual)
- ₹115.2 Cr
- P/E (TTM)
- 40.0×Sector 47.4×
- Promoter holding
- 72.95%+0.00% QoQ
- FII holding
- 0.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 10Financial Results 5Other Announcement 4Earnings Call 4Management Change 3Acquisition 3Results Update 2Price Movement Clarification 2Annual General Meeting 2Product Launch 1Dividend 1Board Meeting Date 1Annual Report 1
Time
3 announcements with these filters
22:23 IST
NSE
Acquisition
RPG Life Sciences Acquisition Worth ₹135 Cr
RPG Life Sciences' subsidiary, RPG Active Pharma, will acquire the API business of Raghava Life Sciences for up to ₹135 Crore, expanding its manufacturing capabilities.
- Value
- ₹135.0 Cr
- manufacturing capacity
- 300.0 KL
13:04 IST
BSE
Acquisition
RPG Life Sciences Acquisition
Clarus Capital I acquired 1,45,113 shares (0.88% stake) of RPG Life Sciences Limited via the open market on April 17, 2026. This acquisition increased its total holding from 4.53% to 5.41%, crossing the 5% disclosure threshold under SEBI SAST Regulations.